Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Maria Infantino and Mariangela Manfredi.
Maria Infantino
Connection Strength
6.677
Mariangela Manfredi
  1. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience. J Med Virol. 2020 Sep; 92(9):1671-1675.
    View in: PubMed
    Score: 0.881
  2. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives. Isr Med Assoc J. 2020 04; 22(4):203-210.
    View in: PubMed
    Score: 0.875
  3. Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experience. Clin Chem Lab Med. 2019 Oct 25; 57(11):1764-1769.
    View in: PubMed
    Score: 0.849
  4. Letter to the Editor relating to Clin Chem Lab Med 2018;56(7):1090-1099. Clin Chem Lab Med. 2019 03 26; 57(4):e45-e46.
    View in: PubMed
    Score: 0.815
  5. Reflex testing of speckled cytoplasmic patterns observed in routine ANA HEp-2 indirect immunofluorescence with a multiplex anti-synthetase dot-blot assay: a multicentric pilot study. Immunol Res. 2018 02; 66(1):74-78.
    View in: PubMed
    Score: 0.753
  6. Prevention and control of COVID-19 in the penitentiary of Florence. Clin Chem Lab Med. 2021 05 26; 59(6):e239-e241.
    View in: PubMed
    Score: 0.231
  7. Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies. J Med Virol. 2021 03; 93(3):1436-1442.
    View in: PubMed
    Score: 0.225
  8. Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al. Ann Rheum Dis. 2020 Aug 04.
    View in: PubMed
    Score: 0.224
  9. Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD. Ann Rheum Dis. 2020 Jul 06.
    View in: PubMed
    Score: 0.223
  10. COVID-19 pneumonia treated with Sarilumab: A clinical series of eight patients. J Med Virol. 2020 11; 92(11):2368-2370.
    View in: PubMed
    Score: 0.222
  11. Correspondence on 'Standardisation of myositis-specific antibodies: where are we today?' Ann Rheum Dis. 2021 07; 80(7):e115.
    View in: PubMed
    Score: 0.210
  12. Are Anti-DFS70 Autoantibodies Protective? Isr Med Assoc J. 2019 Aug; 21(8):509-511.
    View in: PubMed
    Score: 0.209
  13. Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis. J Inflamm Res. 2018; 11:247-252.
    View in: PubMed
    Score: 0.193
  14. Comparison of methods and TAT assessment: Volumetric AQUIOS CL and bead-based FACS CANTO II cytometers. Cytometry B Clin Cytom. 2018 07; 94(4):674-678.
    View in: PubMed
    Score: 0.176
  15. Assessment of humoral and cellular immunity induced by the BNT162b2 SARS-CoV-2 vaccine in healthcare workers, elderly people, and immunosuppressed patients with autoimmune disease. Immunol Res. 2021 12; 69(6):576-583.
    View in: PubMed
    Score: 0.060
  16. Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response"by Bonelli et al. Ann Rheum Dis. 2021 10; 80(10):e166.
    View in: PubMed
    Score: 0.060
  17. Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab. Immunol Res. 2021 08; 69(4):309-311.
    View in: PubMed
    Score: 0.060
  18. Covid vaccination in patients with autoimmune diseases treated with mycophenolate: Let's think back to the recommendations. Autoimmun Rev. 2021 10; 20(10):102908.
    View in: PubMed
    Score: 0.060
  19. Vaccination against SARS-CoV-2 in patients with rheumatic diseases: doubts and perspectives. Clin Exp Rheumatol. 2021 Jan-Feb; 39(1):196-202.
    View in: PubMed
    Score: 0.058
  20. Old and new antirheumatic drugs for the treatment of COVID-19. Joint Bone Spine. 2020 05; 87(3):195-197.
    View in: PubMed
    Score: 0.055
  21. Abatacept: from a budget impact model to cost-effectiveness analysis - data from RCT and real life. Clinicoecon Outcomes Res. 2019; 11:405-409.
    View in: PubMed
    Score: 0.052
  22. The association of solid-phase assays to immunofluorescence increases the diagnostic accuracy for ANA screening in patients with autoimmune rheumatic diseases. Autoimmun Rev. 2018 06; 17(6):541-547.
    View in: PubMed
    Score: 0.048
  23. Ankylosing Spondylitis Treatment after First Anti-TNF Drug Failure. Isr Med Assoc J. 2018 Feb; 20(2):119-122.
    View in: PubMed
    Score: 0.047
  24. Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases. Biologics. 2018; 12:37-41.
    View in: PubMed
    Score: 0.047
  25. Timing of onset affects arthritis presentation pattern in antisyntethase syndrome. Clin Exp Rheumatol. 2018 Jan-Feb; 36(1):44-49.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.